KFDA reviews generic raw materials of Joins

Published: 2010-02-04 06:57:00

Updated: 2010-02-04 06:57:00

The Korea Food and Drug Administration has begun to review raw materials and manufacturing process of Joins generics in four manufacturing sites from last week, a source said recently. Joins is an arthritis drug developed by SK Chemicals Co.

The KFDA review group conducted an on-the-spot inspe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK